DECT Study in Allopurinol-Treated Gout Patients

Trial Identifier: ALLO-402
Sponsor: Ardea Biosciences, Inc.
NCTID:: NCT02393560
Start Date: April 2015
Primary Completion Date: July 2016
Study Completion Date: October 2016
Condition: Immune, Inflammatory & Infections - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Canada, British Columbia Vancouver, British Columbia, Canada, V6J 1S3
New Zealand, Auckland Grafton, Auckland, New Zealand, 1023
USA, CA Irvine, CA, USA, 92618
USA, Colorado Englewood, Colorado, USA, 80113
USA, Colorado Wheat Ridge, Colorado, USA, 80033
USA, GA Atlanta, GA, USA, 30328
USA, OH Cleveland, OH, USA, 44122
USA, OH Lyndhurst, OH, USA, 44124
USA, OH Willoughby Hills, OH, USA, 44094
USA, TX Dallas, TX, USA, 75231
USA, TX Plano, TX, USA, 75075